Rotation of antihypertensive drugs in ethnic groups.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21910

Enrollment

102

Registered

2005-09-13

Start date

2001-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

6 week periods of antihypertensive drug treatment in monotherapy with 3 weeks washout. Drugs: A lisinopril B nebivolol C barnidipine D HCl thiazide E eprosartan.

Interventions

6 week periods of antihypertensive drug treatment in monotherapy with 3 weeks washout. Drugs: A lisinopril B nebivolol C barnidipine D HCl thiazide E eprosartan.

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with uncomplicated hypertension between the ages of 36 and 60 years.

Exclusion criteria

Exclusion criteria: Serious hypertensive organ damage co-morbidity.

Design outcomes

Primary

Measure	Time frame
1. Office blood pressure measured with an automatic device; 2. Side effects measured with a questionnaire.	—

Contacts

Public ContactR.P. Koopmans

Academic Medical Center (AMC), Department of Farmacology and Therapy, P.O. Box 22660

r.p.koopmans@amc.uva.nl+31 (0)20 5669111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)